Corona Medicine Latest News: Companies that are working on treatment for coronavirus

Please follow and like us:

Corona medicine latest news India – There are several companies working on coronavirus cure – Covid-19 was first detected in Wuhan, China in December 2019. It has since affected nearly 21 million people worldwide and has killed over 7 lakh people as of August 2020.

corona medicine latest news india

Since then, the Food and Drug Administration has issued two emergency-use authorizations for COVID-19 treatments – Hydroxychloroquine sulfate and chloroquine phosphate in March 2020 and one for Gilead Sciences Inc’s remdesivir on May 1.

Corona medicine latest news India – medicine for corona – corona medicine in India

List of companies working on coronavirus cure – corona latest news

No drugs or vaccines so far have received FDA approval and so, several pharmaceutical companies are putting together their resources from research & development to create a vaccine to cure the coronavirus.

Here is a list of companies working on coronavirus cure:

Patanjali corona medicine news



Patanjali recently launched a medicine in India called, ‘Divya Coronil tablet’. Although it hasn’t yet been confirmed to effectively help COVID-19 patients, the drug is set to have jointly been made by Patanjali Research Institute and National Institute of Medicine Science, Jaipur.

corona vaccine – corona vaccine news

Must Read: What to do if you are sick with symptoms of coronavirus

companies working on coronavirus vaccine India – Corona medicine latest news India

The CEO of Patanjali Ayurved, Balakrishna said the medicine has been molded into scientific formulas by reading scriptures and Vedas. He also mentioned that the tablet consists of Giloy, ashwagandha, basil, shwassari juice, and atomic oil.

The company claims that ashwagandha acts to keep the corona’s RBD away from the body’s ACE, causing the virus to stay out of a person’s body cells. Giloy prevents the spread of the virus while tulsi attacks the RNS of the virus, acting to prevent its growth.

corona medicine news update – coronavirus medicine – coronavirus news

It was reportedly said that the medicine is for coronavirus but, now it is being called an immunity booster. The Ministry of Health in India has banned the promotion of medicine until it is tested and approved by the Ministry itself. Thus, it cannot be called a medicine to cure coronavirus.

Further down the list, you’ll find those drugs which have been approved to treat patients with mild-moderate symptoms of COVID-19.

Corona medicine latest news India – Glenmark COVID medicine news

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

On 22 June, the company received DCGI approval to launch a new antiviral medicine called, Favipiravir, for treatment of patients with mild to moderate Covid-19 patients.

The company on 26 May announced to begin a new phase 3 clinical trial for patients of moderate Covid-19. This new randomized, open-label study aims to test the combined efficacy of two antiviral drugs, Favipiravir and Umifenovir, as a potential COVID-19 treatment strategy.

coronavirus medicine news – coronavirus medicine news in India – coronavirus medicine India

Also Read: Tips on how to protect yourself from coronavirus

List of companies working on coronavirus cure – companies working on coronavirus vaccine India

Hetero Labs

Hetero Labs

Hetero Labs got a nod to manufacture and sell ‘Remdesivir’. This allowed the use of the drug in ‘restricted emergency use’ only. It is also advised to be given to COVID-19 patients with moderated symptoms.



Cipla got a nod to manufacture and sell ‘Remdesivir’. This allowed the use of the drug in ‘restricted emergency use’ only. It is also advised to be given to COVID-19 patients with moderated symptoms.

Corona medicine latest news India

Sun Pharmaceutical

Sun Pharmaceutical

Sun Pharmaceutical got DCGI nod for the clinical trial of nafamostat mesylate on COVID-19 patients.

Biocon Biologics India

Biocon Biologics India

Biocon Biologics started conducting trials for the novel biologic, itolizumab, to treat cytokine storms, a leading cause of death among severe COVID-19 patients from June 1 onwards. The company also received DCGI approval for the emergency use of ‘CytoSorb’ to treat critical COVID-19 patients near 28th May.

Corona medicine latest news India – corona news india – corona medicine news

Zydus Cadila

This Ahmadabad-based pharmaceutical has emerged as a big leader at the forefront of India’s battle to fight the COVID-19 virus. The company’s research team at Zydus Cadila is constantly working towards an accelerated vaccine research programme that can fight COVID-19. Zydus has adopted a two-pronged approach for the development of a vaccine. This includes a DNA based vaccine and a live attenuated recombinant vaccine to combat the virus. The company is also exploring the use of a biologic drug Interferon alfa-2b to treat the COVID-19 virus.

Serum Institute of India

The 50-year-old Pune-based vaccine giant, Serum Institute of India, is also one of the pharma companies in India that are finding its way to fight against the COVID-19 virus. On June 4, the British drugmaker AstraZeneca said that it has partnered with the Serum Institute of India to supply 1 billion doses of the University of Oxford’s potential COVID-19 vaccine.

The company has forged a partnership with AstraZeneca to produce the coronavirus vaccine. SII will be providing around 400 million doses of coronavirus vaccine by the end of 2020 as a part of the agreement. The company has also tied-up with Codagenix, an American biotech company, to develop a live attenuated vaccine.

Do Read: How to wash fruits and vegetables during coronavirus

Corona medicine latest news India – corona news india – corona medicine news

Bharat Biotech International

Bharat Biotech International has collaborated with the Indian Council for Medical Research to develop a COVID-19 vaccine. With this collaboration, the ICMR will provide continuous support to BBIL for the development of the COVID-19 vaccine.

Indian immunologicals

Indian Immunologicals is one of the largest vaccine manufacturers in the world. They have collaborated with Griffith University of Australia to develop a Coronavirus vaccine, using the latest codon De-optimization technology. According to a statement released by the company, the vaccine has the potential to provide long-lasting protection with just a single-dose administration. Moreover, the vaccine will come with an anticipated safety profile similar to other licensed vaccines used for active Immunisation.


Mynvax is a biotechnology startup involved in making next-generation flu vaccines in India. This startup is situated at the Indian Institute of Science, Bangalore. It has also taken up the responsibility of beating the COVID-19 virus and is developing an indigenous vaccine to prevent COVID-19 infections.

Corona medicine latest news India – corona news india – corona medicine news

Auro vaccines and Gennova Bio pharmaceuticals

Recently Auro Vaccines and Gennova Bio pharmaceuticals announced their entry into the COVID-19 vaccine development race. Both the companies have approached the Department of Biotechnology with their respective vaccine candidates and are looking forward to a quick response.

Vaccine candidate from Panacea Biotec

The yet-unnamed vaccine is being developed by Panacea Biotec which has set up a JV firm in Ireland with US-based Refana Inc for the same purpose. The company will manufacture over 500 million doses of the Covid-19 candidate vaccine. The company also said that over 40 million doses are expected to be available for delivery early next year.

Biological E

The vaccine candidate being developed by theBiological E is currently at the pre-clinical trial level.

Also Read: Why Coloressence ‘Fresh Hands’ sanitizer is one of the best hand sanitizers for you

More medicines being used to treat COVID-19 – companies working on coronavirus cure

corona vaccine – corona vaccine news – medicine for corona

Some other medicines being used to treat coronavirus in India include:

  • Cipremi
  • FabiFlu
  • Covifor
  • Hydroxychloroquine
  • Remdesivir
  • Lopinavir/ritonavir
  • Baloxavir marboxil
  • Darunavir
  • Ribavirin + IFN beta Galidesawer
  • Oseltamivir
  • Umifenovir
  • Camostat mesylate
  • Ruxolitinib
  • Interferon beta

Recommended Reading: History of Pandemics in the world

For more articles like, ‘Corona medicine latest news India’, do follow us on FacebookTwitter, and Instagram for interesting content. For watching our collection of videos, follow us on YouTube.

Disclaimer: None of the medicines mentioned above are fully confirmed to act as cure for the coronavirus.

Leave a Reply

Your email address will not be published.

The content and images used on this site are copyright protected and copyrights vests with their respective owners. We make every effort to link back to original content whenever possible. If you own rights to any of the images, and do not wish them to appear here, please contact us and they will be promptly removed. Usage of content and images on this website is intended to promote our works and no endorsement of the artist shall be implied. Read more detailed ​​disclaimer
Copyright © 2022 All rights reserved.
× How can I help you?